The national coverage determination explicitly outlines patient, clinician, and facilities criteria for qualifying procedures ...
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...
Mamas Mamas, Ruben de Winter, and Paul Knaapen discuss the results of the PROCTOR trial, which explored native vessel versus ...
Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback